Dräger Infinity Acute Care System up to G4.0.3/G4.1/G4.1.1 message integrity
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 7.8 | $0-$5k | 0.00 |
Summary
A vulnerability classified as critical was found in Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitor up to G4.0.3/G4.1/G4.1.1. This impacts an unknown function. Executing a manipulation can lead to message integrity. This vulnerability appears as CVE-2019-25719. The attack may be performed from remote. There is no available exploit. Upgrading the affected component is advised.
Details
A vulnerability classified as critical was found in Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitor up to G4.0.3/G4.1/G4.1.1. This vulnerability affects an unknown function. The manipulation with an unknown input leads to a message integrity vulnerability. The CWE definition for the vulnerability is CWE-924. The product establishes a communication channel with an endpoint and receives a message from that endpoint, but it does not sufficiently ensure that the message was not modified during transmission. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors running software versions VG4.1.1, VG4.0.3, and lower contain network message handling vulnerabilities that allow network-adjacent attackers to spoof or tamper with data and cause denial-of-service conditions. Attackers with access to an enabled Infinity network port or physical proximity to a wireless access point can modify device settings such as alarm states or alarm limits, and overwhelm the system with incoming data causing the device to reboot and lose network functionality.
The advisory is shared for download at static.draeger.com. This vulnerability was named CVE-2019-25719 since 06/02/2026. The exploitation appears to be easy. The attack can be initiated remotely. No form of authentication is required for a successful exploitation. There are neither technical details nor an exploit publicly available.
Upgrading to version G4.2 eliminates this vulnerability.
Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CNA CVSS-B Score: 🔒
CNA CVSS-BT Score: 🔒
CNA Vector: 🔒
CVSSv3
VulDB Meta Base Score: 7.9VulDB Meta Temp Score: 7.8
VulDB Base Score: 7.3
VulDB Temp Score: 7.0
VulDB Vector: 🔒
VulDB Reliability: 🔍
CNA Base Score: 8.6
CNA Vector (VulnCheck): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Message integrityCWE: CWE-924 / CWE-354 / CWE-345
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Yes
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Upgrade: Infinity Acute Care System/Standalone Infinity M540 patient monitor G4.2
Timeline
06/02/2026 Advisory disclosed06/02/2026 CVE reserved
06/02/2026 VulDB entry created
06/02/2026 VulDB entry last update
Sources
Advisory: static.draeger.comStatus: Confirmed
CVE: CVE-2019-25719 (🔒)
GCVE (CVE): GCVE-0-2019-25719
GCVE (VulDB): GCVE-100-367948
Entry
Created: 06/02/2026 17:18Changes: 06/02/2026 17:18 (75)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.